prodchem
Jul 13, 2026
The global helium supply market has entered a critical phase following China's decision to block helium exports and damage to helium production infrastructure at Qatar's Ras Laffan facility. For pharmaceutical manufacturers, the impact extends well beyond industrial gas availability because many quality control laboratories depend on liquid helium to operate Nuclear Magnetic Resonance (NMR) spectroscopy systems.
Unlike many laboratory consumables that can be substituted quickly, liquid helium performs a unique role in maintaining the superconducting magnets that make NMR analysis possible. As supply uncertainty increases, pharmaceutical procurement teams should treat helium availability as an operational priority rather than a routine purchasing activity.
NMR spectroscopy is one of the most important analytical techniques used throughout pharmaceutical manufacturing.
Quality control laboratories use NMR to support:
Structural characterisation of active pharmaceutical ingredients.
Identification of impurities.
Verification of chemical identity.
Process chemistry monitoring.
Product development and formulation studies.
These analytical capabilities rely on superconducting magnets that require continuous cooling with liquid helium.
Without sufficient helium, NMR instruments cannot maintain the magnetic conditions necessary for reliable analysis.
Recent developments have increased pressure on the global helium market from both production and trade perspectives.
Key supply concerns include:
China's restriction on helium exports.
Damage affecting helium production capacity at Qatar's Ras Laffan facility.
Continued uncertainty surrounding future global helium availability.
Together, these developments increase the likelihood of tighter supply allocations, longer delivery times and higher procurement costs for laboratories that depend on liquid helium.
NMR spectroscopy supports critical quality assurance activities throughout pharmaceutical manufacturing.
Any interruption to helium availability may affect:
Routine quality control testing.
Batch release timelines.
Analytical method validation.
Research and development programmes.
Investigation of manufacturing deviations.
Because many laboratories operate on tightly planned analytical schedules, even temporary helium shortages can create workflow disruptions.
Procurement teams supporting pharmaceutical laboratories should respond proactively rather than waiting for supply constraints to affect operations.
Priority actions include:
Confirm liquid helium inventory at every laboratory operating NMR equipment.
Review current supplier allocation policies.
Verify scheduled helium deliveries.
Estimate inventory based on actual laboratory consumption.
Coordinate with laboratory managers regarding future demand forecasts.
These measures provide a clearer picture of operational readiness before supply conditions tighten further.
For laboratories with significant helium consumption, recovery technology may become an increasingly valuable long term investment.
If available helium inventory approaches three months of expected consumption, organizations should begin evaluating helium recovery systems that capture and recycle helium used during laboratory operations.
Potential advantages include:
Reduced dependence on external helium deliveries.
Lower long term helium consumption.
Improved resilience during supply shortages.
Greater operational continuity for critical analytical equipment.
Although installation requires capital investment, recovery systems can strengthen laboratory resilience during periods of market volatility.
Strong communication with industrial gas suppliers has become an essential element of pharmaceutical procurement.
Useful discussions include:
Current allocation policies.
Expected delivery schedules.
Emergency supply procedures.
Long term contract availability.
Regional inventory conditions.
Maintaining regular contact allows laboratories to anticipate supply issues before they interrupt analytical operations.
The current helium supply situation highlights how industrial gas availability can directly influence pharmaceutical quality assurance. Since NMR spectroscopy remains essential for API characterisation, impurity analysis and quality control, procurement teams should immediately verify helium inventories, engage suppliers and evaluate long term resilience measures.
Organizations that strengthen inventory visibility, improve supplier communication and assess helium recovery technologies today will be better prepared to maintain uninterrupted laboratory operations despite ongoing supply uncertainty.
Ready to source helium dependent laboratory support materials and pharmaceutical chemicals from verified global suppliers? Explore competitive offers on our platform today.
Featured Product
Found this useful?
Continue Reading
The transfer of LyondellBasell's European assets to Velogy has introduced fresh uncertainty for buyers of adhesive raw materials. Procurement teams sourcing European EVA, VAM and acrylic acid should closely monitor production plans at the French and German cracker sites.
Fermentation-based marine ingredients such as algal DHA, astaxanthin and beta-glucan offer food manufacturers a more resilient supply chain during periods of global shipping disruption. Procurement teams should understand why production geography matters as much as ingredient performance.
Recent geopolitical developments have renewed attention on PCS Singapore's force majeure position and its implications for regional petrochemical supply. Buyers of polyethylene, polypropylene and ethylene derivatives should reassess supplier communication and supply chain contingency plans.
